Primary study · included by 1 review

The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study

Walter 2007 · Walter M. A., Turtschi C. P., Schindler C., et al. · Journal of Nuclear Medicine · 2007

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Walter 2007 · Reference list; Fig. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · between 2 and 6 months after RIT
Prevalence 0.37 [0.28, 0.47]4 studies · 392 participantsGRADE not reported

1 including review in total.